BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou Q, He Q, Liang LJ. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. World J Gastroenterol 2003; 9(11): 2450-2454 [PMID: 14606074 DOI: 10.3748/wjg.v9.i11.2450]
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2450.htm
Number Citing Articles
1
J.W. Park, K.W. Lee, S.J. Kim, S.H. Choi, J.S. Heo, C.H.D. Kwon, D.J. Kim, Y.S. Han, S.K. Lee, J.W. Joh. Outcome of Patients With Recurrent Hepatocellular Carcinoma in Liver TransplantationTransplantation Proceedings 2006; 38(7): 2121 doi: 10.1016/j.transproceed.2006.06.030
2
Hai Bin Chen, Ke Pan, Mei Kuen Tang, Yiu Loon Chui, Ling Chen, Zhong Jing Su, Zhong Ying Shen, En Min Li, Wei Xie, Kenneth K.H. Lee. Comparative proteomic analysis reveals differentially expressed proteins regulated by a potential tumor promoter, BRE, in human esophageal carcinoma cellsBiochemistry and Cell Biology 2008; 86(4): 302 doi: 10.1139/O08-069
3
Ching-Wen Huang, Ching-Yih Lin, Hsuan-Ying Huang, Hui-Wen Liu, Yi-Ju Chen, Deng-Fuh Shih, Hong-Yaw Chen, Chung-Chou Juan, Chen-Guo Ker, Chi-Ying F. Huang, Chien-Feng Li, Yow-Ling Shiue. CKS1B Overexpression Implicates Clinical Aggressiveness of Hepatocellular Carcinomas but Not p27Kip1 Protein Turnover: an Independent Prognosticator with Potential p27Kip1-Independent Oncogenic Attributes?Annals of Surgical Oncology 2010; 17(3): 907 doi: 10.1245/s10434-009-0779-8
4
Siu Tim Cheung, Ronnie T. Poon. Signaling Pathways in Liver Diseases2005; : 325 doi: 10.1007/3-540-27194-5_27
5
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalWorld Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
6
Xia Zhao, Weihua Yang, Changwen Shi, Wanshan Ma, Jianing Liu, Yunshan Wang, Guosheng Jiang. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cellsTumor Biology 2011; 32(2): 335 doi: 10.1007/s13277-010-0126-5
7
Li Zhao, Dong-Cheng Mou, Xi-Sheng Leng, Ji-Run Peng, Wan-Xiang Wang, Lei Huang, Shu Li, Ji-Ye Zhu. Expression of cancer-testis antigens in hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(14): 2034-2038 doi: 10.3748/wjg.v10.i14.2034
8
Abeer A. Bahnassy, Abdel-Rahman N. Zekri, Samah A. Loutfy, Waleed S. Mohamed, Amrallah Abdel Moneim, Salem E. Salem, Marwa M. Sheta, Ashraf Omar, Heba Al-Zawahry. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinomaExperimental and Molecular Pathology 2011; 91(2): 643 doi: 10.1016/j.yexmp.2011.06.014
9
WEIHUA YANG, XIA ZHAO, FENGYAN PEI, MINGYU JI, WANSHAN MA, YUNSHAN WANG, GUOSHENG JIANG. Activation of the intrinsic apoptosis pathway contributes to the induction of apoptosis in hepatocellular carcinoma cells by valproic acidOncology Letters 2015; 9(2): 881 doi: 10.3892/ol.2014.2739
10
Giovannella Bruscalupi, Mara Massimi, Laura Conti Devirgiliis, Silvia Leoni. Multiple parameters are involved in the effects of cadmium on prenatal hepatocytesToxicology in Vitro 2009; 23(7): 1311 doi: 10.1016/j.tiv.2009.07.018
11
Yadong Wang, Yingzheng Zhao, Xiaoyu Chen. Experimental Study on the Estrogen-Like Effect of Boric AcidBiological Trace Element Research 2008; 121(2): 160 doi: 10.1007/s12011-007-8041-3
12
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3173 doi: 10.1007/978-3-319-26956-6_174
13
Nils-Holger Zschemisch, Christian Liedtke, Uta Dierssen, Yulia A. Nevzorova, Torsten Wüstefeld, Jürgen Borlak, Michael P. Manns, Christian Trautwein. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytesin vivoHepatology 2006; 44(1): 164 doi: 10.1002/hep.21224
14
Azza E El Bassiouny, Mona M Nosseir, Mona K Zoheiry, Noha A Ameen, Ahmed M Abdel-Hadi, Ibrahim M Ibrahim, Suher Zada, Abdel-Hakeem Saad El-Deen, Nora E El-Bassiouni. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinomaWorld Journal of Hepatology 2010; 2(1): 32-41 doi: 10.4254/wjh.v2.i1.32
15
Kian Chuan Sia, Hung Huynh, Alexander Yaw Fui Chung, London Lucien Peng Jin Ooi, Kiat Hon Lim, Kam Man Hui, Paula Yeng Po Lam. Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse ModelMolecular Cancer Therapeutics 2013; 12(8): 1651 doi: 10.1158/1535-7163.MCT-13-0056
16
Ke-Jun Nan, Zhao Jing, Ling Gong. Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> in hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(10): 1425-1430 doi: 10.3748/wjg.v10.i10.1425
17
Jonathan Cools-Lartigue, Jonathan Spicer. Experimental and Clinical Metastasis2013; : 57 doi: 10.1007/978-1-4614-3685-0_7
18
Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven Curley, Yuman Fong, Gregory Gores, Robert Kerlan, Phillipe Merle, Bert O'Neil, Ronnie Poon, Lawrence Schwartz, Joel Tepper, Francis Yao, Daniel Haller, Margaret Mooney, Alan Venook. Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning MeetingJournal of Clinical Oncology 2010; 28(25): 3994 doi: 10.1200/JCO.2010.28.7805
19
Rolf Aamodt, Kristin Jonsdottir, Solveig Norheim Andersen, Johan Bondi, Geir Bukholm, Ida R. K. Bukholm. Differences in Protein Expression and Gene Amplification of Cyclins between Colon and Rectal AdenocarcinomasGastroenterology Research and Practice 2009; 2009: 1 doi: 10.1155/2009/285830
20
Supama Mazumder, Dragos Plesca, Alexandru Almasan. Application of Apoptosis to Cancer Treatment2005; : 145 doi: 10.1007/1-4020-3302-8_6
21
Hong Yang, Xin Zhang, Xiao-yong Cai, Dong-yue Wen, Zhi-hua Ye, Liang Liang, Lu Zhang, Han-lin Wang, Gang Chen, Zhen-bo Feng. From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinomaPeerJ 2017; 5: e3089 doi: 10.7717/peerj.3089
22
Chiun Hsu, Liang-In Lin, Yu-Che Cheng, Zi-Rui Feng, Yu-Yun Shao, Ann-Lii Cheng, Da-Liang Ou. Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionClinical Cancer Research 2016; 22(10): 2555 doi: 10.1158/1078-0432.CCR-15-0499
23
C.H. Golias, A. Charalabopoulos, K. Charalabopoulos. Cell proliferation and cell cycle control: a mini reviewInternational Journal of Clinical Practice 2004; 58(12): 1134 doi: 10.1111/j.1742-1241.2004.00284.x
24
Yohei Saito, Yoshikazu Kuwahara, Yumi Yamamoto, Masatoshi Suzuki, Manabu Fukumoto, Fumihiko Yamamoto. ddY Mice Fed 10% Fat Diet Exhibit High p27KIP Expression and Delayed Hepatocyte DNA Synthesis During Liver RegenerationMetabolic Syndrome and Related Disorders 2018; 16(6): 305 doi: 10.1089/met.2017.0131
25
Yasunobu Matsuda, Toshifumi Wakai, Masayuki Kubota, Masaaki Takamura, Satoshi Yamagiwa, Yutaka Aoyagi, Mami Osawa, Shun Fujimaki, Ayumi Sanpei, Takuya Genda, Takafumi Ichida. Clinical significance of cell cycle inhibitors in hepatocellular carcinomaMedical Molecular Morphology 2013; 46(4): 185 doi: 10.1007/s00795-013-0047-7
26
C Wan, S Hou, R Ni, L Lv, Z Ding, X Huang, Q Hang, S He, Y Wang, C Cheng, X X Gu, G Xu, A Shen. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stabilityOncogene 2015; 34(2): 237 doi: 10.1038/onc.2013.536
27
Yongxiang Luo, Zhaoyin Fu, Peisheng Wu, Dawu Zheng, Xiumei Zhang. The clinicopathological and prognostic significance of P27kip in hepatocellular carcinoma patients: A systemic review and meta-analysisGene 2020; 734: 144351 doi: 10.1016/j.gene.2020.144351
28
Riaan Conradie, Frank J. Bruggeman, Andrea Ciliberto, Attila Csikász‐Nagy, Bela Novák, Hans V. Westerhoff, Jacky L. Snoep. Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complexThe FEBS Journal 2010; 277(2): 357 doi: 10.1111/j.1742-4658.2009.07473.x
29
Sven C.D. van IJzendoorn, Delphine Théard, Johanna M. van der Wouden, Willy Visser, Kacper A. Wojtal, Dick Hoekstra. Oncostatin M-stimulated Apical Plasma Membrane Biogenesis Requires p27Kip1-Regulated Cell Cycle DynamicsMolecular Biology of the Cell 2004; 15(9): 4105 doi: 10.1091/mbc.e04-03-0201
30
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_174-1
31
Leyon Varghese, Chapla Agarwal, Alpana Tyagi, Rana P. Singh, Rajesh Agarwal. Silibinin Efficacy against Human Hepatocellular CarcinomaClinical Cancer Research 2005; 11(23): 8441 doi: 10.1158/1078-0432.CCR-05-1646
32
Yasunobu Matsuda. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinomaWorld Journal of Gastroenterology 2008; 14(11): 1734-1740 doi: 10.3748/wjg.14.1734
33
Yulia A. Nevzorova, Christian Trautwein. Liver Regeneration2015; : 153 doi: 10.1016/B978-0-12-420128-6.00011-7
34
Chinatsu Kasuga, Yukiko Nakahara, Shigeo Ueda, Cynthia Hawkins, Michael D. Taylor, Christian A. Smith, James T. Rutka. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapyJournal of Neurosurgery: Pediatrics 2008; 1(4): 305 doi: 10.3171/PED/2008/1/4/305
35
Yan Geng, Wojciech Michowski, Joel M. Chick, Yaoyu E. Wang, M. Emmanuelle Jecrois, Katharine E. Sweeney, Lijun Liu, Richard C. Han, Nan Ke, Agnieszka Zagozdzon, Ewa Sicinska, Roderick T. Bronson, Steven P. Gygi, Piotr Sicinski. Kinase-independent function of E-type cyclins in liver cancerProceedings of the National Academy of Sciences 2018; 115(5): 1015 doi: 10.1073/pnas.1711477115
36
Hui‐Ching Wang, Wenya Huang, Ming‐Der Lai, Ih‐Jen Su. Hepatitis B virus pre‐S mutants, endoplasmic reticulum stress and hepatocarcinogenesisCancer Science 2006; 97(8): 683 doi: 10.1111/j.1349-7006.2006.00235.x